|
Koru Medical Systems Inc (NASDAQ: KRMD) |
|
|
|
| |
Koru Medical Systems Inc Outlook |
On November 14 2024 the Koru Medical Systems Inc provided following guidance
nnKORU Medical Systems, Inc. Provides Financial Updates and Raises Full-Year Guidance for 2024nn
On November 14, 2024, KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology firm based in Mahwah, New Jersey, announced its financial results for the third quarter ended September 30, 2024. This announcement marks the third consecutive quarter in which the company has experienced double-digit growth, underscoring its commitment to developing innovative solutions in the realm of large volume subcutaneous infusion.
The company reported net revenues for Q3 2024 amounting to $8 million, reflecting a robust performance in their market segment. Capitalizing on this momentum, KORU Medical has adjusted its projections for the remainder of the year, raising its guidance for total revenue, gross margin, and cash reserves anticipated by year-end. While specific figures were not disclosed in the announcement, the upward revision indicates confidence in the company’s growth trajectory.
KORU Medical Systems is dedicated to the advancement, manufacturing, and commercialization of patient-focused medical technologies, particularly those involving subcutaneous infusion therapies. This quarter’s results and positive outlook illustrate the company's ongoing efforts to enhance patient care through innovative medical solutions.,
|
On August 8 2024 the Koru Medical Systems Inc provided following guidance
KORU Medical Systems, Inc. (NASDAQ: KRMD), based in Mahwah, New Jersey, has recently announced its financial results for the second quarter of 2024, demonstrating a record-breaking performance with an impressive 22% increase in revenue year-over-year. This growth highlights the company’s strong position within the medical technology sector, particularly in the development and commercialization of innovative large volume subcutaneous infusion solutions.
For the quarter ending June 30, 2024, KORU Medical reported net revenues totaling $8.4 million. This substantial growth has prompted the company to revise its financial expectations upward, as they raised their full-year guidance for both revenue and gross margins for 2024. While the specific figures for this new guidance have not been disclosed, the positive financial trajectory reflects KORU's commitment to enhancing patient-centric solutions in the healthcare market.
KORU Medical Systems has established itself as a leader in the medical technology space, focusing on creating products that enhance patient care experiences. The robust revenue growth underscores the demand for its innovative infusion solutions and the effectiveness of its business strategies in navigating the competitive landscape of the industry.
Looking ahead, the company’s raised revenue and gross margin guidance signals confidence in continued growth throughout the remainder of 2024. Stakeholders and investors can be encouraged by these developments, as they reflect the organization’s potential for sustained success and its dedication to advancing innovative healthcare solutions that meet the needs of patients.,
|
On March 13 2024 the Koru Medical Systems Inc provided following guidance
Koru Medical Systems, Inc. has recently released its financial results for the fourth quarter and full year of 2023, as well as guidance for the year 2024. The company, which is listed on the NASDAQ under the ticker symbol KRMD, specializes in the development, manufacturing, and commercialization of large volume subcutaneous infusion solutions that are innovative and patient-centered.
For the fourth quarter of 2023, Koru Medical reported net revenues of $7.2 million. This figure indicates the amount of money generated by the company during that period. The full year 2023 financial results were also disclosed, although specific details were not provided in the announcement.
Looking ahead, Koru Medical Systems issued guidance for the full year 2024. This guidance likely includes projections for revenue, expenses, and overall financial performance for the entire year. Investors and stakeholders will use this information to better understand the company's anticipated growth and profitability in the coming months.
These updates reflect Koru Medical's commitment to transparency and accountability in its financial reporting. As a leading player in the medical technology industry, the company's performance and outlook are closely watched by s, investors, and industry observers.
|
On November 8 2023 the Koru Medical Systems Inc provided following guidance
KORU Medical Systems, Inc., a prominent medical technology company specializing in the creation, production, and distribution of user-friendly specialty infusion solutions designed to enhance the quality of life for patients, has announced its third-quarter financial results for the period ending on September 30, 2023, along with updates to its full-year 2023 outlook. The company reported a decline of 10% in net revenue, amounting to $7.0 million in the third quarter.
|
|
|
|
